Bjorn I. Bertelsen

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions.

Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions.

Journal: Translational oncology

Published: May 15, 2025

Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2.

Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 01, 2024

Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.

Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.

Journal: Scientific reports

Published: February 23, 2024

MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer.

MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer.

Journal: BMC cancer

Published: February 15, 2024

Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer.

Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: January 23, 2024

Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer.

Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer.

Journal: Gynecologic oncology

Published: November 01, 2023

MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.

MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.

Journal: Cancer medicine

Published: May 10, 2023

Visceral fat percentage for prediction of outcome in uterine cervical cancer.

Visceral fat percentage for prediction of outcome in uterine cervical cancer.

Journal: Gynecologic oncology

Published: May 05, 2023

What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?

What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?

Journal: Insights into imaging

Published: March 25, 2022

A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival.

A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival.

Journal: Cancers

Published: September 23, 2021

Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.

Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.

Journal: NPJ genomic medicine

Published: April 08, 2021

A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.

A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.

Journal: British journal of cancer

Published: December 22, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026